头部和部区域的骨肉瘤:三级癌症护理中心经验
K S Sandeep1, Priyank Rathod1, Raisha Dalvi1
1Gujarat Cancer and Research Institute, Ahmedabad, India.
概括
头骨肉瘤是一种罕见的,侵袭性的骨瘤. 手术是主要的治疗方法,但结果仍然很差,强调需要改进治疗策略.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 病理学 病理学 病理学
背景情况:
- 头骨肉瘤是一种罕见的,具有挑战性的治疗结果的侵袭性恶性瘤.
- 与四肢骨髓瘤不同,其管理缺乏标准化的指导方针,手术是主要的方法.
研究的目的:
- 为了研究头部和部骨质肉瘤的临床病理和预后特征.
- 分析治疗结果,并确定影响头骨髓瘤患者预后的因素.
主要方法:
- 在2003年至2019年期间,对25名被诊断患有头骨肉瘤的患者进行了回顾性研究.
- 收集的数据包括患者人口统计,瘤部位,治疗方法和生存结果.
主要成果:
- 最常见的部位是下,患者平均年龄为27.5岁,男性略有占主导地位.
- 应用了以手术切除为中心的多模式治疗. 无病生存 (DFS) 和总生存 (OS) 的中位数分别为16个月和36个月,五年生存率为42%.
- 没有手术和积极的手术边缘是显著的负预后因素.
结论:
- 头骨肉瘤是一种具有挑战性的骨瘤,主要影响年轻人,往往预后不佳.
- 手术仍然是治愈治疗的基石,但化疗和放射治疗的作用需要进一步研究.
- 需要进一步的研究,以建立普遍的指导方针来管理这种罕见的恶性瘤.
相关概念视频
Tertiary Healthcare System
1.8K
Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care...
1.8K
Secondary Healthcare System
1.5K
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.5K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


